KDM5B and breast carcinoma: In MCF-7 breast cancer cells overexpressing KDM5B, also known as JARID1B, inhibition of KDME activity increased the sensitivity of breast cancer cells to IR and enhanced radiation-induced damage by blocking the catalytic function of KDM5 enzymes [96].